Many people worldwide do not get sufficient benefit from antidepressant medications and are seeking alternative treatment options. The MOOD research study evaluates a new treatment with a self-administered investigational medical device for alleviating Major Depressive Disorder (MDD) symptoms. The study device is non-invasive and is used by participants at home at convenient times. Compensation for time and travel is available for eligible participants.
The study is sponsored by Neurolief Ltd and the purpose of this research is to evaluate whether the investigational Relivion®DP device is safe and helpful in alleviating Major Depressive Disorder (MDD) symptoms. Here’s a picture of the investigational non-invasive, external neuromodulation device: Relivion®DP. When activated, the device delivers mild electrical stimulation pulses which can be managed by the user and are intended to alleviate major depressive disorder symptoms.
Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this website, is for general information purposes only. Please contact your physician to form a plan that addresses your specific needs.